Brooks Macdonald Group (BRK) Receives GBX 2,229.80 Consensus Target Price from Brokerages

Brooks Macdonald Group (LON:BRK) has been given an average rating of “Buy” by the seven brokerages that are covering the stock, MarketBeat Ratings reports. Three investment analysts have rated the stock with a hold rating and four have given a buy rating to the company. The average 12 month target price among analysts that have issued a report on the stock in the last year is GBX 2,229.80 ($31.30).

A number of equities analysts have recently weighed in on BRK shares. Shore Capital reaffirmed a “hold” rating on shares of Brooks Macdonald Group in a research note on Wednesday, January 24th. Peel Hunt lowered Brooks Macdonald Group to a “hold” rating and set a GBX 2,150 ($30.18) price objective for the company. in a research note on Tuesday, March 13th. Canaccord Genuity reaffirmed a “buy” rating and issued a GBX 2,305 ($32.36) price objective on shares of Brooks Macdonald Group in a research note on Wednesday, January 24th. N+1 Singer reaffirmed a “buy” rating on shares of Brooks Macdonald Group in a research note on Wednesday, January 24th. Finally, Numis Securities reaffirmed a “buy” rating and issued a GBX 2,300 ($32.29) price objective on shares of Brooks Macdonald Group in a research note on Wednesday, January 24th.

How to Become a New Pot Stock Millionaire

LON BRK opened at GBX 1,840 ($25.83) on Wednesday. Brooks Macdonald Group has a twelve month low of GBX 1,810 ($25.41) and a twelve month high of GBX 2,582 ($36.24).

Brooks Macdonald Group (LON:BRK) last released its quarterly earnings data on Tuesday, March 13th. The company reported GBX 47.70 ($0.67) earnings per share for the quarter, topping analysts’ consensus estimates of GBX 47.50 ($0.67) by GBX 0.20 ($0.00). The firm had revenue of GBX 4,879 million during the quarter. Brooks Macdonald Group had a negative return on equity of 1.75% and a negative net margin of 1.63%.

The company also recently announced a dividend, which will be paid on Tuesday, April 24th. Investors of record on Thursday, March 22nd will be given a GBX 17 ($0.24) dividend. The ex-dividend date is Thursday, March 22nd. This represents a dividend yield of 0.85%.

In related news, insider Chris A. MacDonald sold 3,744 shares of the business’s stock in a transaction dated Monday, March 26th. The stock was sold at an average price of GBX 1,845 ($25.90), for a total value of £69,076.80 ($96,963.50).

ILLEGAL ACTIVITY NOTICE: This news story was first posted by Ticker Report and is the sole property of of Ticker Report. If you are viewing this news story on another website, it was copied illegally and reposted in violation of US & international trademark and copyright law. The correct version of this news story can be accessed at https://www.tickerreport.com/banking-finance/3338430/brooks-macdonald-group-brk-receives-gbx-2229-80-consensus-target-price-from-brokerages.html.

About Brooks Macdonald Group

Brooks Macdonald Group plc, through its subsidiaries, provides a range of investment and wealth management services to private clients, pension funds, charities, professional intermediaries, and trustees in the United Kingdom and internationally. It operates through four segments: Investment Management, Financial Planning, Funds and Property Management, and International.

Analyst Recommendations for Brooks Macdonald Group (LON:BRK)

Receive News & Ratings for Brooks Macdonald Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Brooks Macdonald Group and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Somewhat Favorable Media Coverage Somewhat Unlikely to Affect Proteostasis Therapeutics  Stock Price
Somewhat Favorable Media Coverage Somewhat Unlikely to Affect Proteostasis Therapeutics Stock Price
FTD Companies  Getting Somewhat Positive Press Coverage, Report Shows
FTD Companies Getting Somewhat Positive Press Coverage, Report Shows
Koovs  Stock Price Up 28.2%
Koovs Stock Price Up 28.2%
Rigel Pharmaceuticals   Shares Down 6.5%
Rigel Pharmaceuticals Shares Down 6.5%
Dicerna Pharmaceuticals  Shares Up -6.6%
Dicerna Pharmaceuticals Shares Up -6.6%
Barnes & Noble  & Big 5 Sporting Goods  Head to Head Review
Barnes & Noble & Big 5 Sporting Goods Head to Head Review


© 2006-2018 Ticker Report. Google+.